Nagasawa H - Search Results

1

Studies of methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804) 1: effect on free radical scavenging system in mice bearing Ehrlich ascites carcinoma.

Abu-Zeid M, Hori H, Nagasawa H, Uto Y, Inayama S. Abu-Zeid M, et al. Among authors: nagasawa h. Biol Pharm Bull. 2000 Feb;23(2):190-4. doi: 10.1248/bpb.23.190. Biol Pharm Bull. 2000. PMID: 10706382 Free article.

2

Comparison of hypoxic cell radiosensitizers, KIN-804, KIN-844, KIN-806 and TX-1877, on brain and liver metabolizing capacities in mice bearing Ehrlich ascites carcinoma.

Abou-Bedair FA, Hori H, Nagasawa H, Uto Y, Abu-Zeid M, Inayama S. Abou-Bedair FA, et al. Among authors: nagasawa h. Biol Pharm Bull. 2002 May;25(5):591-6. doi: 10.1248/bpb.25.591. Biol Pharm Bull. 2002. PMID: 12033498 Free article.

3

Studies of methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804) 2: effect on certain antioxidant enzyme systems in mice bearing Ehrlich ascites carcinoma.

Abu-Zeid M, Hori H, Nagasawa H, Uto Y, Inayama S. Abu-Zeid M, et al. Among authors: nagasawa h. Biol Pharm Bull. 2000 Feb;23(2):195-8. doi: 10.1248/bpb.23.195. Biol Pharm Bull. 2000. PMID: 10706383 Free article.

4

Design of hypoxia-targeting drugs as new cancer chemotherapeutics.

Nagasawa H, Uto Y, Kirk KL, Hori H. Nagasawa H, et al. Biol Pharm Bull. 2006 Dec;29(12):2335-42. doi: 10.1248/bpb.29.2335. Biol Pharm Bull. 2006. PMID: 17142959 Free article. Review.

5

In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.

Tada T, Nakajima T, Onoyama Y, Murayama C, Mori T, Nagasawa H, Hori H, Inayama S. Tada T, et al. Among authors: nagasawa h. Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):601-5. doi: 10.1016/0360-3016(94)90465-0. Int J Radiat Oncol Biol Phys. 1994. PMID: 8005823

6

The immunopotentiation effects of the bifunctional radiosensitizer KIN-806 in comparison with its analogs KIN-804 and KIN-844.

Inomata T, Ogawa Y, Nishioka A, Hamada N, Ito S, Kariya S, Yoshida S, Nagasawa H, Hori H, Inayama S. Inomata T, et al. Among authors: nagasawa h. Oncol Rep. 1999 Nov-Dec;6(6):1209-12. doi: 10.3892/or.6.6.1209. Oncol Rep. 1999. PMID: 10523682

7

[Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].

Tada T, Nakajima T, Onoyama Y, Nagasawa H, Hori H, Inayama S. Tada T, et al. Among authors: nagasawa h. Nihon Igaku Hoshasen Gakkai Zasshi. 1992 May 25;52(5):688-90. Nihon Igaku Hoshasen Gakkai Zasshi. 1992. PMID: 1508643 Japanese.

8

A convenient screening test for hypoxic cell radiosensitizers/cytotoxins.

Hori H, Yokoyama H, Nagasawa H, Murayama C, Mori T, Yonei S, Satoh T, Inayama S. Hori H, et al. Among authors: nagasawa h. Biol Pharm Bull. 1994 Dec;17(12):1676-8. doi: 10.1248/bpb.17.1676. Biol Pharm Bull. 1994. PMID: 7735218 Free article.

9

Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.

Jin CZ, Nagasawa H, Shimamura M, Uto Y, Inayama S, Takeuchi Y, Kirk KL, Hori H. Jin CZ, et al. Among authors: nagasawa h. Bioorg Med Chem. 2004 Sep 15;12(18):4917-27. doi: 10.1016/j.bmc.2004.06.039. Bioorg Med Chem. 2004. PMID: 15336271

10

Lung metastasis suppression of the bifunctional new radiosensitizer KIN-806.

Inomata T, Ogawa Y, Itoh S, Kariya S, Hamada N, Nishioka A, Yoshida S, Nagasawa H, Hori H, Inayama S. Inomata T, et al. Among authors: nagasawa h. Int J Mol Med. 1999 Sep;4(3):257-60. doi: 10.3892/ijmm.4.3.257. Int J Mol Med. 1999. PMID: 10425275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,530 results

Search Page

Filters